MAZE vs. EVLV
MAZE (Maze Therapeutics, Inc) and EVLV (Evolv Technologies Holdings Inc) are both stocks. MAZE operates in Biotechnology (Healthcare), while EVLV operates in Security & Protection Services (Industrials). Over the past year, MAZE returned 77.49% vs 17.57% for EVLV. At a 0.02 correlation, their price movements are largely independent.
Performance
MAZE vs. EVLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MAZE achieves a -41.95% return, which is significantly lower than EVLV's -14.94% return.
MAZE
- 1D
- -0.17%
- 1M
- -10.79%
- YTD
- -41.95%
- 6M
- -38.11%
- 1Y
- 77.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
EVLV
- 1D
- -0.81%
- 1M
- 1.16%
- YTD
- -14.94%
- 6M
- -13.12%
- 1Y
- 17.57%
- 3Y*
- -1.38%
- 5Y*
- -9.60%
- 10Y*
- —
MAZE vs. EVLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MAZE Maze Therapeutics, Inc | -41.95% | 157.01% |
EVLV Evolv Technologies Holdings Inc | -14.94% | 79.00% |
Correlation
The correlation between MAZE and EVLV is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.02 |
Fundamentals
MAZE:
$1.30B
EVLV:
$1.08B
MAZE:
-$2.63
EVLV:
-$0.21
MAZE:
3.79
EVLV:
8.94
MAZE:
$0.00
EVLV:
$160.23M
MAZE:
-$1.15M
EVLV:
$79.75M
MAZE:
-$126.66M
EVLV:
-$39.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MAZE vs. EVLV — Risk / Return Rank
MAZE
EVLV
MAZE vs. EVLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Maze Therapeutics, Inc (MAZE) and Evolv Technologies Holdings Inc (EVLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MAZE | EVLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.53 | ||
| Sortino ratioReturn per unit of downside risk | +1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.10 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 0.40 | +1.03 |
| Martin ratioReturn relative to average drawdown | 3.16 | 0.75 | +2.41 |
Loading charts...
Drawdowns
MAZE vs. EVLV - Drawdown Comparison
The maximum MAZE drawdown since its inception was -54.51%, smaller than the maximum EVLV drawdown of -84.50%. Use the drawdown chart below to compare losses from any high point for MAZE and EVLV.
Loading charts...
Drawdown Indicators
| MAZE | EVLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.51% | -84.50% | +29.99% |
Max Drawdown (1Y)Largest decline over 1 year | -54.51% | -44.06% | -10.45% |
Max Drawdown (3Y)Largest decline over 3 years | — | -72.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -84.21% | — |
Current DrawdownCurrent decline from peak | -53.60% | -44.13% | -9.47% |
Average DrawdownAverage peak-to-trough decline | -20.99% | -50.29% | +29.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.60% | 23.37% | +1.23% |
Volatility
MAZE vs. EVLV - Volatility Comparison
The current volatility for Maze Therapeutics, Inc (MAZE) is 11.72%, while Evolv Technologies Holdings Inc (EVLV) has a volatility of 15.37%. This indicates that MAZE experiences smaller price fluctuations and is considered to be less risky than EVLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MAZE | EVLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.72% | 15.37% | -3.65% |
Volatility (6M)Calculated over the trailing 6-month period | 56.26% | 38.87% | +17.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.54% | 52.43% | +37.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.20% | 86.01% | +8.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 94.20% | 80.57% | +13.63% |
Dividends
MAZE vs. EVLV - Dividend Comparison
Neither MAZE nor EVLV has paid dividends to shareholders.
Financials
MAZE vs. EVLV - Financials Comparison
This section allows you to compare key financial metrics between Maze Therapeutics, Inc and Evolv Technologies Holdings Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MAZE and EVLV have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EVLV has higher volatility (15.37%) compared to MAZE (11.72%). In terms of maximum drawdown, MAZE dropped -54.51% vs EVLV's -84.50%.
MAZE currently has the higher Sharpe Ratio (0.87 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MAZE and EVLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer